
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
Keywords: ADE; antibody-dependent enhancement; DENV; dengue virus; LATDV; live attenuated tetravalent dengue vaccine; PBMC; peripheral blood mononuclear cells; SAE; serious adverse event; WHO; World Health Organization; Dengue vaccine; Vaccine safety; Post-licensur